These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11122758)
1. Endothelial function as a therapeutic target in coronary artery disease. Sharma N; Andrews TC Curr Atheroscler Rep; 2000 Jul; 2(4):303-7. PubMed ID: 11122758 [TBL] [Abstract][Full Text] [Related]
2. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications. Zeiher AM; Schächinger V Z Kardiol; 1994; 83 Suppl 4():7-14. PubMed ID: 7856284 [TBL] [Abstract][Full Text] [Related]
3. Endothelial function and cardiovascular prevention: role of blood lipids, exercise, and other risk factors. Paterick TE; Fletcher GF Cardiol Rev; 2001; 9(5):282-6. PubMed ID: 11520452 [TBL] [Abstract][Full Text] [Related]
4. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options. Britten MB; Zeiher AM; Schächinger V J Intern Med; 1999 Apr; 245(4):315-27. PubMed ID: 10356593 [TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography and the changing paradigm in coronary artery disease. Schelbert HR Z Kardiol; 2000; 89 Suppl 4():IV55-60. PubMed ID: 10810777 [TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction and coronary risk reduction. Charo S; Gokce N; Vita JA J Cardiopulm Rehabil; 1998; 18(1):60-7. PubMed ID: 9494884 [TBL] [Abstract][Full Text] [Related]
7. Current trials on angiotensin-converting enzyme inhibitors and endothelial dysfunction. Anderson T Can J Cardiol; 1998 Jul; 14 Suppl D():33D-34D. PubMed ID: 9713430 [TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction and cardiovascular risk factors. Grover-Páez F; Zavalza-Gómez AB Diabetes Res Clin Pract; 2009 Apr; 84(1):1-10. PubMed ID: 19185380 [TBL] [Abstract][Full Text] [Related]
9. [Endothelial dysfunction and angiotensin-converting enzyme inhibitors in coronary disease]. Mélon P Rev Med Liege; 1998 Jun; 53(6):353-4. PubMed ID: 9713215 [TBL] [Abstract][Full Text] [Related]
10. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction. Schlaifer JD; Wargovich TJ; O'Neill B; Mancini GB; Haber HE; Pitt B; Pepine CJ Am J Cardiol; 1997 Dec; 80(12):1594-7. PubMed ID: 9416943 [TBL] [Abstract][Full Text] [Related]
12. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure. Hornig B; Arakawa N; Drexler H Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors, calcium blockers, estrogen and antioxidants in secondary prevention of coronary disease. Vogel R Can J Cardiol; 1998 Jul; 14 Suppl D():8D-10D. PubMed ID: 9713419 [TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in coronary artery disease. Lüscher TF; Tanner FC; Tschudi MR; Noll G Annu Rev Med; 1993; 44():395-418. PubMed ID: 8476260 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). Anderson TJ; Elstein E; Haber H; Charbonneau F J Am Coll Cardiol; 2000 Jan; 35(1):60-6. PubMed ID: 10636260 [TBL] [Abstract][Full Text] [Related]